Immunotoxin fusion proteins and means for expression thereof
The present invention described and shown in the specification and drawings provides novel recombinant DT-based immunotoxins, and, more specifically anti-T cell immunotoxin fusion proteins. Also provided are immunotoxins that can be expressed in bacterial, yeast, or mammalian cells. The invention also provides means for expression of the immunotoxin fusion protein. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.
1. A nucleic acid encoding an anti-T cell immunotoxin fusion protein, comprising, from the amino terminus, a truncated diphtheria toxin moiety, a connector, and two single chain Fvs of the variable region of a UCHT1 antibody, wherein the two single chain Fvs comprise VL, L, VH, L, VL, L, VH, wherein L is a Gly-Ser linker, wherein VL and VH are the variable light and heavy domains of the anti-CD3 antibody UCHT1, and wherein the truncated diphtheria toxin moiety comprises at least the first 385 amino acids of full length native diphtheria toxin.
2. A vector, comprising the nucleic acid of claim 1 .
3. The vector of claim 2 , wherein the vector is a plasmid.
4. A cell, comprising the nucleic acid of claim 1 , wherein the cell is an E. coli cell.